https://stock.noler.com/us/stock/akero-therapeutics-inc https://stock.noler.com/us/stock/akero-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/akero-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/akero-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/akero-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/akero-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/akero-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/akero-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/aoci https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-amortized-cost-current https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/akero-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/akero-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/akero-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/akero-therapeutics-inc/capitalization-longterm-debt-and-equity https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/akero-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/akero-therapeutics-inc/common-stock-dividends-per-share-cash-paid https://stock.noler.com/us/stock/akero-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/akero-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/akero-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/akero-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/akero-therapeutics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/akero-therapeutics-inc/current-assets https://stock.noler.com/us/stock/akero-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/akero-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/akero-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/akero-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/akero-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/akero-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/akero-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/akero-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/akero-therapeutics-inc/depreciation https://stock.noler.com/us/stock/akero-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/akero-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/akero-therapeutics-inc/dividends-per-share https://stock.noler.com/us/stock/akero-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/akero-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/akero-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/akero-therapeutics-inc/eps https://stock.noler.com/us/stock/akero-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/akero-therapeutics-inc/expense-related-to-distribution-or-servicing-and-underwriting-fees https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/akero-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/akero-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/akero-therapeutics-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/akero-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/akero-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/akero-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/income-tax https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/akero-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/akero-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/akero-therapeutics-inc/interest-and-other-income https://stock.noler.com/us/stock/akero-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/akero-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/akero-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/akero-therapeutics-inc/land-subject-to-ground-leases https://stock.noler.com/us/stock/akero-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/akero-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/akero-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/akero-therapeutics-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/akero-therapeutics-inc/loans-payable https://stock.noler.com/us/stock/akero-therapeutics-inc/loans-payable-current https://stock.noler.com/us/stock/akero-therapeutics-inc/long-term-loans-payable https://stock.noler.com/us/stock/akero-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/akero-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/akero-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/akero-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/akero-therapeutics-inc/net-income https://stock.noler.com/us/stock/akero-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/akero-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/akero-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-income https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/akero-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/akero-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/akero-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/akero-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/akero-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-for-repurchase-of-private-placement https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/akero-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/akero-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/akero-therapeutics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/akero-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-issuance-of-redeemable-preferred-stock https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/akero-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/akero-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/akero-therapeutics-inc/public-float https://stock.noler.com/us/stock/akero-therapeutics-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/repayments-of-long-term-lines-of-credit https://stock.noler.com/us/stock/akero-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/akero-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/akero-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/akero-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/akero-therapeutics-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/akero-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/akero-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/akero-therapeutics-inc/share-price https://stock.noler.com/us/stock/akero-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/akero-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/akero-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/akero-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/akero-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/akero-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/akero-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/akero-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/akero-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/akero-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/akero-therapeutics-inc/total-assets https://stock.noler.com/us/stock/akero-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/akero-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/akero-therapeutics-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/akero-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/akero-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/akero-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/akero-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/akero-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/akero-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/akero-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/akero-therapeutics-inc/weighted-average-number-of-shares-restricted-stock